1Centers for Diease Control.MMWR Morb Mortal Wkly Rep[R].1989,38:64-68,73-76.
2Centers for Diease Control.MMWR Morb Mortal Wkly Rep[R].1991,40(RR-12):42-44.
3WHO.World health statistics annual.Vol 1.Vital Statistics and Causes of Death.1976.
4Sisk JE,Moskowitz AJ,Whang W,et al.Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people[J].JAMA,1997,278:1333-1339.
5Herman CM,Chen GJ,High KP.Pneumococcal penicillin resistance and the cost-effectiveness of pneumococcal vaccine[J].Infect Med,1998,15:223,236-237,241-243,275.
8Hazeline Roche, Anders Ha kansson, Susan K Holl- ingshead, et al. Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infection and Immunity, 2003, 71(3): 1033-1041.
9Susan K Hollingshead, Robert Becker, David E Briles. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infection and Immunity, 2000, 68(10): 5889-5900.
10Dennis O Gor, Xuedong Ding, David E Briles. Relation- ship between surface accessibility for ppmA, psaA, and pspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Infect Immun, 2005, 73(3): 1304-1312.
